SCHEMBL3843623

SCHEMBL3843623

C=CCc1cc(Cl)c(CC=C)cc1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 4/20 0.52
GABRB2 P47870 4/20 0.52
POLB P06746 2/20 0.44
SRD5A1 P18405 1/20 0.42
MEN1 O00255 2/20 0.41
GAA P10253 2/20 0.41
MAPT P10636 2/20 0.41
CNR1 P21554 2/20 0.41
CNR2 P34972 2/20 0.41
KMT2A Q03164 2/20 0.41
ALOX5 P09917 1/20 0.41
GABRB1 P18505 1/20 0.41
RXRA P19793 1/20 0.41
GABRA5 P31644 1/20 0.41
GABRA3 P34903 1/20 0.41
GABRA2 P47869 1/20 0.41
ACE2 Q9BYF1 1/20 0.41
SIRT3 Q9NTG7 1/20 0.41
AKR1B1 P15121 2/20 0.40
XDH P47989 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10981064 0.88 GABRA1 (0.47) GABRA1GABRB2POLBSRD5A1MEN1
SCHEMBL1420694 0.87 GABRA1 (0.64) GABRA1GABRB2POLBSRD5A1MEN1
SCHEMBL1244606 0.82 GABRA1 (0.59) GABRA1GABRB2POLBSRD5A1MEN1
SCHEMBL7737611 0.82 GABRA1 (0.59) GABRA1GABRB2POLBSRD5A1MEN1
SCHEMBL6309438 0.80 GABRA1 (0.61) GABRA1GABRB2POLBSRD5A1MEN1
SCHEMBL11766536 0.80 GABRA1 (0.40) GABRA1GABRB2POLBMEN1GAA
SCHEMBL18191248 0.79 GABRA1 (0.43) GABRA1GABRB2POLBSRD5A1MEN1
SCHEMBL4633136 0.78 GABRA1 (0.36) GABRA1GABRB2POLBMEN1GAA
SCHEMBL8522175 0.77 POLB (0.44) GABRA1GABRB2POLBSRD5A1MEN1
SCHEMBL1744767 0.77 GABRA1 (0.58) GABRA1GABRB2POLBSRD5A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1586598-B1 Process for preparation of polymeric, phosphorus-containing compositions INVISTA TECH SARL (CH) 2009-09-09 EP disclosed
EP-1448503-B1 PROCESS FOR PREPARING 3,3',6,6'-TETRAALKYL-2,2'-BIPHENOLS AND 3,3',6,6'-TETRAALKYL-5,5'-DIHALO-2,2'-BIPHENOLS INVISTA TECH SARL (US) 2008-01-30 EP disclosed
EP-1586598-A1 Process for preparation of polymeric, phosphorus-containing compositions E.I. du Pont de Nemours and Company (US) 2005-10-19 EP disclosed
EP-1571172-A1 Polymeric, phosphorus-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions E.I. du Pont de Nemours and Company (US) 2005-09-07 EP disclosed
CN-1617900-A Polymeric phosphorus-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions DU PONT (US) 2005-05-18 CN disclosed
EP-1448668-A1 POLYMERIC, PHOSPHOROUS-CONTAINING COMPOSITIONS AND THEIR USE IN HYDROCYANATION, ISOMERIZATION AND HYDROFORMYLATION REACTIONS E. I. du Pont de Nemours and Company (US) 2004-08-25 EP disclosed
US-20040049087-A1 Process for preparing 3,3',6,6'-tetraalkyl-2,2'-biphenols and 3,3',6,6'-tetraalkyl-5,5'-dihalo-2,2'-biphenols INVISTA NORTH AMERICA S.A.R.L. (F/K/A ARTEVA NORTH AMERICA S.A.R.L.) 2004-03-11 US disclosed
US-20030135014-A1 Polymeric, phosphorus-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions INVISTA NORTH AMERICA S.A.R.L. 2003-07-17 US disclosed
WO-2003046049-A1 POLYMERIC, PHOSPHOROUS-CONTAINING COMPOSITIONS AND THEIR USE IN HYDROCYANATION, ISOMERIZATION AND HYDROFORMYLATION REACTIONS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2003-06-05 WO disclosed
US-6555718-B1 Oxidatively coupling of phenols in presence of Lewis Acid catalysts E. I. DU PONT DE NEMOURS AND COMPANY 2003-04-29 US disclosed
US-6489517-B1 CHLORINATING DIALKYLPHENOL, OXIDATIVELY COUPLING PRODUCT IN POLAR APROTIC SOLVENT TO PRODUCE DICHLOROTETRAALKYLBIPHENOL, DECHLORINATING TO PRODUCE TETRAALKYLBIPHENOL, BROMINATING OR IODINATING IF DESIRED E. I. DU PONT DE NEMOURS AND COMPANY 2002-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040049087-A1 Process for preparing 3,3',6,6'-tetraalkyl-2,2'-biphenols and 3,3',6,6'-tetraalkyl-5,5'-dihalo-2,2'-biphenols CYP2B6, CYP26B1, UGT1A6 GABRA1 841/4885GABRB2 607/4885POLB 653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.